SFX by Ex Libris Inc.

Title:	Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
Source:	Acs Medicinal Chemistry Letters [1948-5875] Cho, Young yr:2012

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	") Discovered through X-ray Fragment Screening." Journal of medicinal chemistry. 59.11: 5356-5367.
description	2.	Kobayashi, T. "Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor." ACS medicinal chemistry letters 5.8 (2014): 889-893.
description	3.	Larson, Steven M. "Radioimmunotherapy of human tumours." Nature Reviews. Cancer 15.6 (2015): 347-360.
description	4.	Golkowski, M. "Rapid profiling of protein kinase inhibitors by quantitative proteomics." MedChemComm 5.3 (2014): 363-369.
description	5.	Anna, Anna W. "Synthesis of Biphenyl Proteomimetics as Estrogen Receptor-α Coactivator Binding Inhibitors." Organic letters 11.23 (2009): 5370-5373.
description	6.	"A Hexylchloride-Based Catch-and-Release System for Chemical Proteomic Applications." ACS chemical biology. 8.4: 691-699.
description	7.	Van Den Heuvel. "A Closed Parameterization of DNA-Damage by Charged Particles, as a Function of Energy - A Geometrical Approach." PLoS One 9.10 (2014).
description	8.	Larson, Steven M. "Prostate cancer: Better use of bone scans in prostate cancer." Nature reviews. 12.4: 190-191.
description	9.	Sharpless, Norman E. E. "Forging a signature of in vivo senescence." Nature Reviews. Cancer 15.7 (2015): 397-408.
description	10.	Wang, Rongsheng E. "An Immunosuppressive Antibody–Drug Conjugate." Journal of the American Chemical Society 137.9 (2015): 3229-3232.
description	11.	Ranjitkar, P. "Correction to “Affinity-Based Probes Based on Type II Kinase Inhibitors”." Journal of the American Chemical Society 135.2 (2013): 948-948.
description	12.	Wang, J. "A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis." Molecular & cellular proteomics 13.3 (2014): 876-86.
description	13.	Chung, Young K. "A Versatile Synthetic Platform Based on Bicyclo[4.1.0]heptenes." Journal of inorganic and organometallic polymers and materials 24.1 (2014): 15-32.
description	14.	Daydé Cazals, A. "De novo design, synthesis and pharmacological evaluation of new azaindole derivatives as dual inhibitors of Abl and Src kinases." MedChemComm 3.7 (2012): 788-800.
description	15.	Matsumoto, Y. "Effect of FR167653, a novel inhibitor of tumor necrosis factor-alpha and interleukin-1beta synthesis on lipopolysaccharide-induced hepatic microvascular dysfunction in mice." Shock 17.5 (2002): 411-5.
description	16.	Sammons, M. "A convenient and rapid approach for the synthesis of 1-benzyl-3-heterocyclic pyrazoles." Tetrahedron letters 50.39 (2009): 5479-5481.
description	17.	Murphy, Jaclyn M. "Meta Halogenation of 1,3-Disubstituted Arenes via Iridium-Catalyzed Arene Borylation." Journal of the American Chemical Society 129.50 (2007): 15434-15435.
description	18.	MuÃoz-EspÃn, D. "Cellular senescence: from physiology to pathology." Nature reviews. Molecular cell biology 15.7 (2014): 482-496.
description	19.	Tzschucke, C. h. "Arenes to anilines and aryl ethers by sequential iridium-catalyzed borylation and copper-catalyzed coupling." Organic letters 9.5 (2007): 761-764.
description	20.	Murphy, Jaclyn M. "Ruthenium-Catalyzed Regiospecific Borylation of Methyl C-H Bonds." Journal of the American Chemical Society 128.42 (2006): 13684-13685.